Ioannis Sotiropoulos, PhD, Medical School, University of Minho, Braga, Portugal, highlights the focus of recent clinical trials in the early phases of Alzheimer’s disease and the importance of early diagnosis and prognosis based on peripheral biomarkers, such as exosomes in the blood. Additionally, Dr Sotiropoulos discusses precision medicine. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

свернуть